What is the main objective of the GENIAC-PRIZE project?

It is aimed at strengthening domestic generative AI development capabilities and promoting social implementation.

Which organizations are leading the GENIAC-PRIZE project?

The project is led by the Ministry of Economy, Trade and Industry (METI) and the New Energy and Industrial Technology Development Organization (NEDO).

How many applicants were selected as finalists for Theme I?

Ingenta has been selected as one of 8 finalists from a total of 58 applicants in Theme I.

What is the title of the proposal submitted by the joint team of Ingenta and Biomimetics Sympathies Inc.?

The proposal is titled "Drug Discovery AI that Capitalizes on Failure Data: An Autonomous Cooperative Hypothesis Generation System using Domestic LLM x Graph Technology".

What kind of data does the proposed drug discovery AI system structure and utilize?

The proposed system structures previously underutilized experimental failure data, research records, and literature information.

AI News NQ Analysis

[First in Japan] Selected as the only "GENIAC-PRIZE" finalist in both the pharmaceutical field and technical document handling.

NQ Score 100/100

AI Summary (NQ-processed)

Ingenta Inc., in collaboration with Biomimetics Sympathies Inc., has been selected as one of the eight finalists for the "GENIAC-PRIZE," a project led by METI and NEDO to promote generative AI implementation. Their proposal features an autonomous cooperative hypothesis generation system using domestic LLM and Graph technology to structure and reuse underutilized experimental failure data and research records, aiming to advance R&D processes in the pharmaceutical and manufacturing industries.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main objective of the GENIAC-PRIZE project?: A: It is aimed at strengthening domestic generative AI development capabilities and promoting social implementation.
Q: Which organizations are leading the GENIAC-PRIZE project?: A: The project is led by the Ministry of Economy, Trade and Industry (METI) and the New Energy and Industrial Technology Development Organization (NEDO).
Q: How many applicants were selected as finalists for Theme I?: A: Ingenta has been selected as one of 8 finalists from a total of 58 applicants in Theme I.
Q: What is the title of the proposal submitted by the joint team of Ingenta and Biomimetics Sympathies Inc.?: A: The proposal is titled "Drug Discovery AI that Capitalizes on Failure Data: An Autonomous Cooperative Hypothesis Generation System using Domestic LLM x Graph Technology".
Q: What kind of data does the proposed drug discovery AI system structure and utilize?: A: The proposed system structures previously underutilized experimental failure data, research records, and literature information.